Accuity, a provider of payment routing data, AML screening software and services, has announced the appointment of Hugh Jones IV as chief executive officer of Accuity and NRS.
Previously the president of the two businesses, Jones has over 15 years of experience building corporate value by creating rich data streams that provide new solutions to difficult business challenges. He has been successful in developing top executive teams, leading sales efforts and negotiating complicated business deals.
Prior to joining the company, Jones spent five years building IntrinsiQ Research into the dominant leader in information management for the oncology market. As the executive vice president, he and his partners built the software applications that enabled US-based oncologists to optimally treat their patients and allowed the bio-pharmaceutical industry to analyse real-time oncology usage data to thoroughly understand their products. Previously, Jones led Datamonitor’s Healthcare practice as the global managing director. In addition to many corporate roles, Jones participated frequently on both syndicated and custom engagements in areas such as product portfolio optimisation, acquisition strategies, field force structure, market assessments, product launch strategy and various eHealth issues.
Accuity has also announced the appointment of Richard Antoneck as chief financial officer. Antoneck, previously the senior vice president of financial operations at SourceMedia, has over 14 years of experience within the financial industry.
“Hugh has had a very positive transformative impact on Accuity and NRS since becoming president in 2008,” said Martin Maleska, chairman of Accuity Holdings, Inc, an Investcorp company. “Under his leadership, the businesses have developed powerful suites of proprietary solutions that offer customers levels of quality and service that are unrivalled in the industries they serve.”
“Both Accuity and NRS enjoy preferred provider market positions in the vast majority of their business lines,” said Jones. “The companies are very well-positioned to capitalise on strong secular industry trends with their strategic solutions and targeted growth initiatives. I am excited for the future of both businesses.”
Subscribe to our newsletter
